Preneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial

SIMPLE SUMMARY: Pancreatic cancer patients who undergo curative surgery are still likely to recur. We therefore analyzed the data of the 493 patients from the PRODIGE 24-CCTG PA 6 trial, which validated the benefit of adjuvant mFOLFIRINOX regimen over gemcitabine after pancreatic adenocarcinoma rese...

Descripción completa

Detalles Bibliográficos
Autores principales: Legrand, Théo, Salleron, Julia, Conroy, Thierry, Marchal, Frédéric, Thomas, Jacques, Monard, Laure, Biagi, James Jim, Lambert, Aurélien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406034/
https://www.ncbi.nlm.nih.gov/pubmed/36010938
http://dx.doi.org/10.3390/cancers14163945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406034/
https://www.ncbi.nlm.nih.gov/pubmed/36010938
http://dx.doi.org/10.3390/cancers14163945

Ejemplares similares